Difference between revisions of "ICRP Glossary"
Jump to navigation
Jump to search
| Line 543: | Line 543: | ||
*[[Pericarditis]] | *[[Pericarditis]] | ||
| − | |||
| − | |||
*[[Personal/Individual Monitoring]] | *[[Personal/Individual Monitoring]] | ||
| Line 553: | Line 551: | ||
*[[Platelet-derived growth factor]] | *[[Platelet-derived growth factor]] | ||
| − | |||
| − | |||
*[[Potential exposure]] | *[[Potential exposure]] | ||
| Line 565: | Line 561: | ||
*[[Prevailing circumstances]] | *[[Prevailing circumstances]] | ||
| − | |||
| − | |||
*[[Principle of application of dose limits]] | *[[Principle of application of dose limits]] | ||
| Line 583: | Line 577: | ||
*[[Prophylaxis]] | *[[Prophylaxis]] | ||
| − | |||
| − | |||
*[[Protection strategy]] | *[[Protection strategy]] | ||
| Line 610: | Line 602: | ||
*[[Radiation detriment]] | *[[Radiation detriment]] | ||
| − | |||
| − | |||
*[[Radiation level]] | *[[Radiation level]] | ||
